136 related articles for article (PubMed ID: 23715162)
21. Synaptophysin expression in neuroendocrine neoplasms as determined by immunocytochemistry.
Gould VE; Wiedenmann B; Lee I; Schwechheimer K; Dockhorn-Dworniczak B; Radosevich JA; Moll R; Franke WW
Am J Pathol; 1987 Feb; 126(2):243-57. PubMed ID: 3103452
[TBL] [Abstract][Full Text] [Related]
22. Utility of Phox2b immunohistochemical stain in neural crest tumours and non-neural crest tumours in paediatric patients.
Warren M; Matsuno R; Tran H; Shimada H
Histopathology; 2018 Mar; 72(4):685-696. PubMed ID: 28986989
[TBL] [Abstract][Full Text] [Related]
23. A Comparison of GATA3, TTF1, CD10, and Calretinin in Identifying Mesonephric and Mesonephric-like Carcinomas of the Gynecologic Tract.
Pors J; Cheng A; Leo JM; Kinloch MA; Gilks B; Hoang L
Am J Surg Pathol; 2018 Dec; 42(12):1596-1606. PubMed ID: 30148742
[TBL] [Abstract][Full Text] [Related]
24. Essential role of Gata transcription factors in sympathetic neuron development.
Tsarovina K; Pattyn A; Stubbusch J; Müller F; van der Wees J; Schneider C; Brunet JF; Rohrer H
Development; 2004 Oct; 131(19):4775-86. PubMed ID: 15329349
[TBL] [Abstract][Full Text] [Related]
25. GATA3 Expression in Normal Skin and in Benign and Malignant Epidermal and Cutaneous Adnexal Neoplasms.
Mertens RB; de Peralta-Venturina MN; Balzer BL; Frishberg DP
Am J Dermatopathol; 2015 Dec; 37(12):885-91. PubMed ID: 26595821
[TBL] [Abstract][Full Text] [Related]
26. Value of thyroid transcription factor-1 and surfactant apoprotein A in the differential diagnosis of pulmonary carcinomas: a study of 109 cases.
Zamecnik J; Kodet R
Virchows Arch; 2002 Apr; 440(4):353-61. PubMed ID: 11956814
[TBL] [Abstract][Full Text] [Related]
27. Hand2 Immunohistochemistry in the Diagnosis of Paragangliomas and Other Neuroendocrine Neoplasms.
Soukup J; Manethova M; Stejskal V; Novakova M; Duskova J; Hornychova H; Hacova M; Staniczkova-Zambo I; Zelinka T; Kosak M; Cesak T; Netuka D; Ryska A; Gabalec F
Endocr Pathol; 2024 Mar; 35(1):14-24. PubMed ID: 38416360
[TBL] [Abstract][Full Text] [Related]
28. GATA3 Is a Sensitive and Specific Marker of Benign and Malignant Mesonephric Lesions in the Lower Female Genital Tract.
Howitt BE; Emori MM; Drapkin R; Gaspar C; Barletta JA; Nucci MR; McCluggage WG; Oliva E; Hirsch MS
Am J Surg Pathol; 2015 Oct; 39(10):1411-9. PubMed ID: 26135559
[TBL] [Abstract][Full Text] [Related]
29. Gata3 participates in a complex transcriptional feedback network to regulate sympathoadrenal differentiation.
Moriguchi T; Takako N; Hamada M; Maeda A; Fujioka Y; Kuroha T; Huber RE; Hasegawa SL; Rao A; Yamamoto M; Takahashi S; Lim KC; Engel JD
Development; 2006 Oct; 133(19):3871-81. PubMed ID: 16943277
[TBL] [Abstract][Full Text] [Related]
30. Synaptophysin and neurofilament proteins as markers for neuroendocrine tumors.
Miettinen M
Arch Pathol Lab Med; 1987 Sep; 111(9):813-8. PubMed ID: 2820344
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical expression of CRX in extracranial malignant small round cell tumors.
Terry J; Calicchio ML; Rodriguez-Galindo C; Perez-Atayde AR
Am J Surg Pathol; 2012 Aug; 36(8):1165-9. PubMed ID: 22790857
[TBL] [Abstract][Full Text] [Related]
32. Cdx2 as a marker for neuroendocrine tumors of unknown primary sites.
Erickson LA; Papouchado B; Dimashkieh H; Zhang S; Nakamura N; Lloyd RV
Endocr Pathol; 2004; 15(3):247-52. PubMed ID: 15640551
[TBL] [Abstract][Full Text] [Related]
33. Cytokeratin 7 and 20 and thyroid transcription factor 1 can help distinguish pulmonary from gastrointestinal carcinoid and pancreatic endocrine tumors.
Cai YC; Banner B; Glickman J; Odze RD
Hum Pathol; 2001 Oct; 32(10):1087-93. PubMed ID: 11679943
[TBL] [Abstract][Full Text] [Related]
34. Utility of GATA3 in the differential diagnosis of pheochromocytoma.
Perrino CM; Ho A; Dall CP; Zynger DL
Histopathology; 2017 Sep; 71(3):475-479. PubMed ID: 28374498
[TBL] [Abstract][Full Text] [Related]
35. GATA-3 and FOXA1 expression is useful to differentiate breast carcinoma from other carcinomas.
Davis DG; Siddiqui MT; Oprea-Ilies G; Stevens K; Osunkoya AO; Cohen C; Li XB
Hum Pathol; 2016 Jan; 47(1):26-31. PubMed ID: 26527523
[TBL] [Abstract][Full Text] [Related]
36. Microtubule-associated protein-2: a new sensitive and specific marker for pulmonary carcinoid tumor and small cell carcinoma.
Liu Y; Sturgis CD; Grzybicki DM; Jasnosz KM; Olson PR; Tong M; Dabbs DD; Raab SS; Silverman JF
Mod Pathol; 2001 Sep; 14(9):880-5. PubMed ID: 11557784
[TBL] [Abstract][Full Text] [Related]
37. BRAF and endocrine tumors: mutations are frequent in papillary thyroid carcinomas, rare in endocrine tumors of the gastrointestinal tract and not detected in other endocrine tumors.
Perren A; Schmid S; Locher T; Saremaslani P; Bonvin C; Heitz PU; Komminoth P
Endocr Relat Cancer; 2004 Dec; 11(4):855-60. PubMed ID: 15613458
[TBL] [Abstract][Full Text] [Related]
38. Surfactant proteins and thyroid transcription factor-1 in pulmonary and breast carcinomas.
Bejarano PA; Baughman RP; Biddinger PW; Miller MA; Fenoglio-Preiser C; al-Kafaji B; Di Lauro R; Whitsett JA
Mod Pathol; 1996 Apr; 9(4):445-52. PubMed ID: 8729987
[TBL] [Abstract][Full Text] [Related]
39. A tissue microarray-based comparative analysis of novel and traditional immunohistochemical markers in the distinction between adrenal cortical lesions and pheochromocytoma.
Sangoi AR; McKenney JK
Am J Surg Pathol; 2010 Mar; 34(3):423-32. PubMed ID: 20154585
[TBL] [Abstract][Full Text] [Related]
40. PHOX2B is a Sensitive and Specific Marker for the Histopathological Diagnosis of Pheochromocytoma and Paraganglioma.
Miyauchi M; Akashi T; Furukawa A; Uchida K; Tamura T; Ando N; Kirimura S; Shintaku H; Yamamoto K; Ito T; Miura K; Kayamori K; Ariizumi Y; Asakage T; Kudo A; Tanabe M; Fujii Y; Ishibashi H; Okubo K; Murakami M; Yamada T; Takemoto A; Bae Y; Eishi Y; Ohashi K
Endocr Pathol; 2022 Dec; 33(4):506-518. PubMed ID: 36029394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]